Cross-sectional study of the proportion of antibiotic use during childbirth in full-term deliveries in Finland
- PMID: 36681812
- PMCID: PMC9862572
- DOI: 10.1186/s12884-023-05368-0
Cross-sectional study of the proportion of antibiotic use during childbirth in full-term deliveries in Finland
Abstract
Purpose: In developed countries, data on the frequency of antibiotics given to mothers during childbirth are limited beyond the overall effect of all various prophylactic indications. Also, data on the impact of such antibiotics to the well-being of term babies are scarce. We aimed to characterize the frequency of antibiotic use during childbirth of term pregnancy. Secondly, we assessed whether the use of antibiotics was associated with any symptoms in infants.
Methods: This was a cross-sectional study of 1019 term deliveries of women participating in the prospective Health and Early Life Microbiota (HELMi) birth cohort study between March 2016 and March 2018 in the capital region of Finland. The data on antibiotic use were collected from the hospital records.
Results: In total, 37% of the mothers received antibiotics during childbirth and 100% in Caesarean Sects. (17% of the deliveries). Less than 5% of antibiotics were non-prophylactic. In vaginal deliveries, the most common indication (18%) was prophylaxis for Group B Streptococcus. The most frequently used antibiotics were cefuroxime (22%) and benzylpenicillin (15%), and 56% received only one dose. In infants exposed to antibiotics during delivery, defecation frequency was higher during the first months (p-value < 0.0001- 0.0145), and weight gain was higher at the age of three months (p-value 0.0371).
Conclusion: More than every third new-born in a developed country is exposed to antibiotics during birth. Our findings support the hypothesis that maternal antibiotics given during birth have an impact on the well-being of the infants. These findings should inform current policies for prophylactic antibiotics in childbirth.
Keywords: Antibiotic prophylaxis; Caesarean section; Group B Streptococcus; Infant; Pregnancy.
© 2023. The Author(s).
Conflict of interest statement
There are no competing interests.
Figures
Similar articles
-
Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study.BJOG. 2016 May;123(6):983-93. doi: 10.1111/1471-0528.13601. Epub 2015 Sep 28. BJOG. 2016. PMID: 26412384
-
Maternal and institutional characteristics associated with the administration of prophylactic antibiotics for caesarean section: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health.BJOG. 2014 Mar;121 Suppl 1:66-75. doi: 10.1111/1471-0528.12632. BJOG. 2014. PMID: 24641537
-
Preventing neonatal group B streptococcal infection. Intrapartum antibiotic prophylaxis in some high-risk situations.Prescrire Int. 2011 Mar;20(114):72-7. Prescrire Int. 2011. PMID: 21648230 Review.
-
Impact of intrapartum antimicrobial prophylaxis upon the intestinal microbiota and the prevalence of antibiotic resistance genes in vaginally delivered full-term neonates.Microbiome. 2017 Aug 8;5(1):93. doi: 10.1186/s40168-017-0313-3. Microbiome. 2017. PMID: 28789705 Free PMC article.
-
Effect of intrapartum antibiotics on the intestinal microbiota of infants: a systematic review.Arch Dis Child Fetal Neonatal Ed. 2020 Mar;105(2):201-208. doi: 10.1136/archdischild-2018-316659. Epub 2019 Jul 11. Arch Dis Child Fetal Neonatal Ed. 2020. PMID: 31296695
Cited by
-
Resilience to Global Health Challenges Through Nutritional Gut Microbiome Modulation.Nutrients. 2025 Jan 22;17(3):396. doi: 10.3390/nu17030396. Nutrients. 2025. PMID: 39940253 Free PMC article. Review.
-
Intrapartum and postpartum antibiotic use in seven low- and middle-income countries: Findings from the A-PLUS trial.BJOG. 2025 Jan;132(1):72-80. doi: 10.1111/1471-0528.17930. Epub 2024 Aug 14. BJOG. 2025. PMID: 39140197 Clinical Trial.
-
Sources of gut microbiota variation in a large longitudinal Finnish infant cohort.EBioMedicine. 2023 Aug;94:104695. doi: 10.1016/j.ebiom.2023.104695. Epub 2023 Jul 1. EBioMedicine. 2023. PMID: 37399600 Free PMC article.
-
Investigating prenatal and perinatal factors on meconium microbiota: a systematic review and cohort study.Pediatr Res. 2024 Jan;95(1):135-145. doi: 10.1038/s41390-023-02783-z. Epub 2023 Aug 17. Pediatr Res. 2024. PMID: 37591927 Free PMC article.
-
Human milk oligosaccharide composition is affected by season and parity and associates with infant gut microbiota in a birth mode dependent manner in a Finnish birth cohort.EBioMedicine. 2024 Jun;104:105182. doi: 10.1016/j.ebiom.2024.105182. Epub 2024 Jun 4. EBioMedicine. 2024. PMID: 38838470 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical